Discover
LNAI
Lunai Bioworks Inc.
2.76
1 x 2.64
1 x 3.31
bid
ask
+
0.00
0.00%
210 @ 09:11 AM
2.82 +0.06 (2.17%)
| Ytd | -60.85% | |
| 1y | -73.05% |
day range
1.21
52 week range
28.00
| Open | Prev Close | 2.76 | Low | High | Mkt Cap | 12.51M | |||
| Vol | 0.00 | Avg Vol | 1.18M | EPS | -0.74 | P/E | -3.74 | Forward P/E | N/A |
| Beta | 0.37 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-15 | 50-d Avg | 2.81 | 200-d Avg | 5.38 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 20.94K | ||
| Revenues (USD) | 20.94K | ||
| Gross Profit | 20.94K | ||
| Operating Expenses | 1.45M | ||
| Research and Development Expense | 15.95K | ||
| Selling, General and Administrative Expense | 1.42M | ||
| Operating Income | -1.43M | ||
| Interest Expense | 128.02K | ||
| Net Income | -2.57M | ||
| Net Income Common Stock | -2.57M | ||
| Net Income Common Stock (USD) | -2.57M | ||
| Consolidated Income | -2.57M | ||
| Earnings per Basic Share | -0.80 | ||
| Earnings per Basic Share (USD) | -0.80 | ||
| Earnings per Diluted Share | -0.80 | ||
| Earning Before Interest & Taxes (EBIT) | -2.44M | ||
| Earning Before Interest & Taxes (USD) | -2.44M | ||
| Weighted Average Shares | 3.12M | ||
| Weighted Average Shares Diluted | 3.12M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.16M | ||
| Cash and Equivalents (USD) | 3.16M | ||
| Current Assets | 3.73M | ||
| Property, Plant & Equipment Net | 12.96K | ||
| Total Assets | 9.86M | ||
| Debt Current | 1.28M | ||
| Total Debt | 1.41M | ||
| Current Liabilities | 19.28M | ||
| Debt Non-Current | 131.32K | ||
| Total Liabilities | 19.41M | ||
| Accumulated Retained Earnings (Deficit) | -512.01M | ||
| Accumulated Other Comprehensive Income | -155.70K | ||
| Shareholders Equity | -9.55M | ||
| Shareholders Equity (USD) | -9.55M | ||
| Assets Non-Current | 6.13M | ||
| Total Debt (USD) | 1.41M | ||
| Goodwill and Intangible Assets | 6.08M | ||
| Liabilities Non-Current | 131.32K | ||
| Trade and Non-Trade Payables | 12.68M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 19.63K | ||
| Net Cash Flow from Financing | 3.70M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.66M | ||
| Issuance (Purchase) of Equity Shares | 4.50M | ||
| Issuance (Repayment) of Debt Securities | -796.04K | ||
| Net Cash Flow from Operations | -1.03M | ||
| Effect of Exchange Rate Changes on Cash | -13.03K | ||
| Share Based Compensation | 168.99K | ||